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The Stingray LP balloon (Boston Scientiﬁc, Marlborough, MA) is frequently used to facilitate distal true lumen re-entry in case of subintimal
guidewire entry during chronic total occlusion (CTO) percutaneous coronary intervention (PCI) [1,2]. There is limited data on the failure modes
of the Stingray LP balloon.
We investigated the Manufacturer and User Facility Device Experience (MAUDE) database for reports on Stingray LP failure from January
2016 to December 2020 (the device was approved in December 2015).
The database was last accessed on January 3rd, 2021, by two independent reviewers (RM and MM). The MAUDE database is publicly available and de-identiﬁed and no institutional review board approval was
required. The outcomes this study was the modes of failure and their
clinical consequences. The percentages reported in the study represent
only the events reported to the MAUDE registry and doesn't represent
the overall complications of the Stingray LP balloon as the denominator
is unknown.
A total of 95 reports were found during the study period. After excluding duplicates and irrelevant reports (n = 23), reports on the
initial Stingray balloon (n = 16), and Stingray wire reports (n =
5), our ﬁnal cohort included 51 reports. The most common mode of
failure was balloon rupture after delivery (45%), followed by failure
of the wire to pass through the catheter (15.7%), and shaft fracture
(15.7%) (Table 1). Serious clinical consequences were rare with no
injury to the patient in 96% of the reports and completed procedure

Abbreviation: MAUDE, Manufacturer and User Facility Device Experience database;
CTO, chronic total occlusion; PCI, percutaneous coronary intervention.
⁎ Corresponding author at: Minneapolis Heart Institute and Minneapolis Heart Institute
Foundation, Abbott Northwestern Hospital, 920 E 28th Street #300, Minneapolis 55407,
MN, USA.
E-mail address: esbrilakis@gmail.com (E.S. Brilakis).

in 87%. Coronary perforation and tamponade occurred in 1 report,
emergency cardiac surgery was required in 1 report and no patients
died.
Our study is the ﬁrst to describe the modes of failure of Stingray LP
balloon since its approval in 2015. We found that reports on Stingray
LP failure were rare (51 over 5 years) with no signiﬁcant clinical consequences in most cases. The most common Stingray LP balloon malfunction was rupture after delivery. This could be due to balloon
deformation during aggressive advancement attemtps, for example
through heavily calciﬁed and tortuous coronary segments. Another potential cause of rupture is inﬂation of the Stingray LP balloon at higher
than recommended (3–4 atm is recommended in the instructions for
use) pressure.
Preparing the subintimal track can facilitate delivery of the Stingray
LP balloon, but also carries a risk of creating a subintimal hematoma that
could hinder subsequent reentry attempts. Microcatheter advancement
to the reentry zone usually sufﬁces, although in some cases inﬂation
with a small (1.0–1.5 mm) balloon may be required. Aggressive advancement attempts should be avoided as they can compromise the
structural integrity of the Stingray LP balloon, that may lead to kinking
of the balloon shaft that may not allow subsequent guidewire insertion
(15.7% of the reports) and could even lead to balloon shaft fracture
(15.7% of the reports).
Inability to visualize the balloon was the mode of failure in 11.8% of
the reports. This is likely related to suboptimal balloon preparation,
which is laborious requiring aspiration with a 20 cm3 dry syringe X 3,
followed by connection with a 3 cm3 syringe that contains 100% contrast. Multiple views and use of higher magniﬁcation can help better visualize the Stingray LP balloon and its relation with the distal true
lumen. Alternatively, the “double blind stick and swap technique” can
be used for reentry [3], during which a stiff guidewire is advanced
through both exit ports of the Stingray balloon, followed by exchange
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Table 1
Complications and failure modes of Stingray LP balloon as reported to the MAUDE registry.

None.

N = 51
Target vessel, n (%)
Left anterior descending artery
Left circumﬂex
Right coronary artery
Not mentioned

10 (19.6%)
2 (3.9%)
22 (43.1%)
17 (33.3%)

Failure mode, n (%)
Balloon rupture after delivery
Failure of guidewire to pass through Stingray catheter (stuck wire)
Shaft fracture
Failure to visualize the balloon markers under ﬂuoroscopy
Balloon fracture before delivery
Failure to cross the lesion
Failure of balloon inﬂation
Failure of balloon deﬂation

23 (45.1%)
8 (15.7%)
8 (15.7%)
6 (11.8%)
4 (7.8%)
3 (5.9%)
1 (2%)
1 (2%)

Clinical consequences, n (%)
No injury to the patient
Completed percutaneous coronary intervention
Aborted procedure
Coronary perforation leading to tamponade
Surgery
Death

49 (96.1%)
43 (87.3%)
5 (9.8%)
1 (2%)
1 (2%)
0 (0%)
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for a polymer jacketed guidewire that is also advanced through both
exit ports until reentry is achieved.
Failure to cross the lesion was the mode of failure in 5.7% of the reports, although this does not represent an inherent device failure. Failure to cross may be due to subintimal hematoma formation that could
be reduced by aspiration, either though the Stingray balloon itself or
through an over the wire balloon or a microcatheter [4,5]. Alternatively
the reentry zone may be moved more distally (“bobsled” technique).
Reentry failure may also be due to heavy calciﬁcation that could be overcome by using stiff tip guidewires.
Our study is limited by the selection bias resulting from the retrospective analysis from the MAUDE and selective optional reporting by
healthcare professionals. Moreover, the incidence of each mode of failure cannot be accurately determined as the study lacks a denominator.
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